Primary Site >> Liver Cancer
Gene >> PIK3CG
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Hepatocyte-specific Pten-deficient mice as a novel model for nonalcoholic steatohepatitis and hepatocellular carcinoma. PMID: 16214396 |
Ref: FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway. PMID: 17237822 |
Ref: Ablation of phosphoinositide-3-kinase class II alpha suppresses hepatoma cell proliferation. PMID: 19591801 |
Ref: Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib. PMID: 20707757 |
Ref: Nicotine stimulated dendritic cells could achieve anti-tumor effects in mouse lung and liver cancer. PMID: 20957418 |
Ref: Prognostic impact of pERK in advanced hepatocellular carcinoma patients treated with sorafenib. PMID: 23845703 |
Ref: Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway. PMID: 24521981 Ref: Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts. PMID: 25360116 |
Ref: miR-502 inhibits cell proliferation and tumor growth in hepatocellular carcinoma through suppressing phosphoinositide 3-kinase catalytic subunit gamma. PMID: 26163264 |
Ref: A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer. PMID: 27023566 Ref: Revealing the Effects of the Herbal Pair of Euphorbia kansui and Glycyrrhiza on Hepatocellular Carcinoma Ascites with Integrating Network Target Analysis and Experimental Validation. PMID: 27143956 |
Ref: ASIC1a mediates the drug resistance of human hepatocellular carcinoma via the Ca(2+)/PI3-kinase/AKT signaling pathway. PMID: 27918554 |